Dermatology Research

Publications

The UCLA Division of Dermatology frequently shares research and insights in top-tier academic journals. Read their latest articles here.

October 2026

  1. Akiska YM, Fu J, Castelo-Soccio L, Mathes E, Mirmirani P, Jamerson T, Sibbald C; and The Pediatric Low-Dose Oral Minoxidil Consensus Expert Group; Spagnol Abraham L, Ali A, Arkin LM, Asfour L, Austin K, Bhoyrul B, Buethe MG, Callender VD, Cheng CE, Chitreddy V, Craddock M, Cranwell W, Craiglow BG, Desai NS, Doche I, Duque-Estrada B, Eisman S, Friedman A, Giacaman A, Hordinsky M, Jabbari A, Kang HB, King B, Kushnir-Grinbaum D, Mesinkovska N, Netravali IA, Oboite M, Olsen EA, Orlow SJ, Oza VS, Ovcharenko Y, Paller A, Patel S, Piliang M, Pirmez R, Rakowska A, Müller-Ramos P, Saceda-Corralo D, Salkey KS, Bellodi Schmidt F, Sinclair R, Lo Sicco K, Soung J, Steuer M, Senna MM, Tarbox M, Tosti A, Turbeville J, Wall D. Low-Dose Oral Minoxidil Use for Pediatric Hair Disorders: An International Consensus Statement. JAMA Dermatol. 2026 Sep 30. doi: 10.1001/jamadermatol.2026.3749. Epub ahead of print. PMID: 42814435.
  2. Armstrong A, Kircik L, Metelitsa A, Warren RB, Rodriguez A, Volc S, Issa N, Chovatiya R, von Eyben R, Festini T, Johansen P, Ehst B. Tralokinumab Versus Dupilumab for the Treatment of Atopic Dermatitis with Moderate-to-Severe Hand Involvement: A Matching-Adjusted Indirect Comparison. Dermatol Ther (Heidelb). 2026 Oct 2. doi: 10.1007/s13555-026-01922-8. Epub ahead of print. PMID: 42825999.
  3. Rosenbach M, Boghosian T, Granovsky R, Rimmer S, Chiu Y, Elewski BE, Rosmarin D, Said J, Trinidad JC, Zheng L, Goh C; American Academy of Dermatology Emerging Disease Task Force. 2026 Ebola Virus Disease Outbreak: What Dermatologists Should Know. J Am Acad Dermatol. 2026 Oct 9:S0190-9622(26)03721-7. doi: 10.1016/j.jaad.2026.10.010. Epub ahead of print. PMID: 42854847.
  4. Li R, Ramirez Y, Stone L, Klufas T, Zhou AE, Tucci C, Beynet DP, Lo Sicco K, Grant-Kels JM. Closing the Gap: The Ethics of Non-Physician Delegation in Mohs Reconstruction. J Am Acad Dermatol. 2026 Oct 10:S0190-9622(26)03722-9. doi: 10.1016/j.jaad.2026.09.127. Epub ahead of print. PMID: 42858914.
  5. Park I, Bayrouti A, MacIntyre D, Le V, Nguyen KB. Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns. Dermatol Pract Concept. 2026 Jul 31;16(3). doi: 10.5826/dpc.1603a6731. PMID: 42858381.
  6. Noveir SD, Agrawal N. Moyamoya disease presenting as galactorrhea. JCEM Case Rep. 2026 Oct 13;4(11):luag296. doi: 10.1210/jcemcr/luag296. PMID: 42871260; PMCID: PMC13658269.
  7. Zhou AE, Gronbeck C, Kim JJ, Yu S, Feng H, Klufas DM. The State of Mohs Micrographic Surgery in 2025-2026: Current Challenges, Pressures, and the Path Forward. J Clin Aesthet Dermatol. 2026 Sep;19(9):73-78. PMID: 42877396; PMCID: PMC13668094.
  8. Teles RMB, Benabdessalem C, Perrie J, Wei C, West J, de Andrade Silva BJ, Andrade PR, Mansky LA, Divaka P, Fischbacher L, Lam K, Ma F, Gu Y, Rategh K, Brown M, Pillai A, Lumamba K, Naidoo T, French SM, Romdhane E, Barbouche MR, Klechevsky E, Colonna M, Steyn AJC, Bensinger SJ, Barber DL, Rammeh S, Dulai PS, Bryson BD, Pellegrini M, Belisle JT, Bloom BR, Modlin RL. Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia. Nat Commun. 2026 Aug 21;17(1):10817. doi: 10.1038/s41467-026-76814-8. PMID: 42875426; PMCID: PMC13669344.
  9. Fleshner L, Chan R, Klufas T, Grant-Kels JM, Zhou AE. Reply to Botto et al's "Applicant interview metrics and preference signaling in dermatology: A serial cross-sectional study". J Am Acad Dermatol. 2026 Oct 17:S0190-9622(26)03784-9. doi: 10.1016/j.jaad.2026.09.134. Epub ahead of print. PMID: 42892382.
  10. Armstrong AW, Kim HJ, Pink AE, Gorelick J, Rossi M, Trzeciak M, Deleuran M, Nakajima S, Prajapati VH. Initiating Biologics in Atopic Dermatitis: Global Practices and Recommendations from the AMAZE Project. Dermatol Ther (Heidelb). 2026 Oct 19. doi: 10.1007/s13555-026-01942-4. Epub ahead of print. PMID: 42895682.
  11. McInnes IB, Stein Gold L, Bissonnette R, Lebwohl MG, Reyes-Servin O, Cafone J, Yang YW, Chakravarty SD, Iaconangelo C, Li S, Shagroni T, Lozenski K, Armstrong AW, Merola JF. Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials. J Psoriasis Psoriatic Arthritis. 2026 Oct 18:24755303261494526. doi: 10.1177/24755303261494526. Epub ahead of print. PMID: 42898453; PMCID: PMC13677984.
  12. Ajmani A, Sanjeev R, Klufas T, Zhou AE, Davis JC, Grant-Kels JM. Ethical Implications of Patient-Requested Cessation of Mohs Micrographic Surgery with Residual Tumor. J Am Acad Dermatol. 2026 Oct 21:S0190-9622(26)03819-3. doi: 10.1016/j.jaad.2026.10.059. Epub ahead of print. PMID: 42906781.
  13. Freeman M, Gates G, Ahronowitz I. Merkel Cell Carcinoma Masquerading as Dermatitis. Cureus. 2026 Sep 19;18(9):e116561. doi: 10.7759/cureus.116561. PMID: 42903405; PMCID: PMC13680730.
  14. Yang LJ, Cheng B, Yang E, Rangel SM, Griffith JW, Chamlin SL, Hogeling M, Schoch J, Rehmus W, Castelo-Soccio L, Antaya R, Bercovitch L, O'Haver J, Hunt R, Paller AS. Stigma from vitiligo in children and adolescents is linked to reduced mental health: a cross-sectional study. J Am Acad Dermatol. 2026 Oct 27:S0190-9622(26)03830-2. doi: 10.1016/j.jaad.2026.10.068. Epub ahead of print. PMID: 42946018.
  15. Wang K, Quintana J, Yang V, Kawasumi K, Kam CY. The cutaneous vasculature: Development, repair, and disease. Semin Cell Dev Biol. 2026 Oct 27;185-187:103704. doi: 10.1016/j.semcdb.2026.103704. Epub ahead of print. PMID: 42945618.
  16. Lee E, Samlowski W, Reynolds B, Sadrolashrafi K. Case Report: Improvement in neurologic symptoms and remission following non-operative management of locally advanced cutaneous squamous cell carcinoma of the head and neck following cemiplimab therapy: two cases. Front Oncol. 2026 Oct 15;16:1975694. doi: 10.3389/fonc.2026.1975694. PMID: 42959034; PMCID: PMC13716587.
  17. Stein Gold L, Sofen HL, Siu K, Syeed S, Edson-Heredia E, Mitchell B, Goddard E, Kranz B, Gillespie-Akar L, Armstrong AW. Real-World Patient and Disease Characteristics, Treatment Outcomes and Satisfaction in Psoriasis: A Cross-Sectional and Retrospective Comparison of Advanced Therapies and Severities. Dermatol Ther (Heidelb). 2026 Oct 29. doi: 10.1007/s13555-026-01899-4. Epub ahead of print. PMID: 42957860.
  18. Gold LS, Armstrong AW, Vender RB, Soung J, Pink AE, Cafone J, Edem BE, Reyes-Servin O, Jiang J, Cresswell K, DeKlotz CMC, Miller-Kassamali M, Yang YW, Lebwohl MG. Consistency of skin clearance with icotrokinra across patient subgroups with plaque psoriasis. J Eur Acad Dermatol Venereol. 2026 Oct 29. doi: 10.1111/jdv.70817. Epub ahead of print. PMID: 42954748.
  19. Paller AS, Stein Gold LF, Simpson EL, Zaenglein AL, Armstrong AW, Tollefson MM, Soong W, Lee LW, Devani AR, Forman SB, Siri DD, Kallender H, Angel B, Li Q, Purohit VS, Eichenfield LF. 52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study. J Am Acad Dermatol. 2026 Oct 30:S0190-9622(26)03835-1. doi: 10.1016/j.jaad.2026.10.072. Epub ahead of print. PMID: 42962926.
View all Dermatology Publications